- Choice of the add-on therapy to metformin in type 2 diabetes patients in Romania2017 | Second Faculty of Medicine, Third Faculty of Medicine
- Interferon-beta or azathioprine as add-on therapies in patients with active multiple sclerosis2012 | First Faculty of Medicine
- Levetiracetam add-on therapy in our patiens with refraktory epilepsyPublication without faculty affiliation
- Levetiracetam add-on therapy efficacy in refraktory epileptic patiens with ''high-frequency'' partial seizuresPublication without faculty affiliation
- Zoledronic acid add-on therapy for standard-risk Ewing sarcoma patients in the Ewing 2008R1 trial2023 | Second Faculty of Medicine
- Novel approaches in schizophrenia-from risk factors and hypotheses to novel drug targets2021 | First Faculty of Medicine
- Efficacy and safety of exenatide as add-on therapy for patients with type 2 diabetes with an intensive insulin regimen : A randomized double-blind trial2021 | Faculty of Medicine in Pilsen
- Anxiety and depression profile of our refraktory epilepsy patients with self-report of seizure frequency and cluster ''high frequency'' partial seizures on levetiracetam add-on therapyPublication without faculty affiliation
- A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols (Sativex (R)), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis2011 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols (Sativex (R)), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis2011 | Publication without faculty affiliation
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. C2011-0401Publication without faculty affiliation
- Antipsychotics in treatment of predominant negative symptoms in schizophrenia: update of guidelines2020 | Faculty of Medicine in Hradec Králové
- Pharmacological Influence on Glutamatergic System in Schizophrenia2006 | Faculty of Medicine in Hradec Králové
- Ginkgo biloba EGb761 extract and its use in psychiatry2018 | First Faculty of Medicine
- Pharmacological Influence on Glutamatergic System in Schizophrenia2006 | First Faculty of Medicine
- Novel approaches in pharmacological treatment of epilepsy2021 | Second Faculty of Medicine
- Use of mucolytics in COPD: A Delphi consensus study2020 | Faculty of Medicine in Hradec Králové
- Novel approaches to chronic obstructive pulmonary disease treatment2016 | Third Faculty of Medicine
- Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study2015 | First Faculty of Medicine
- Current and future therapeutic options for the treatment of the generalized form of myasthenia gravis2023 | First Faculty of Medicine
- The Role of Nutraceuticals in Statin Intolerant Patients2018 | First Faculty of Medicine
- Newest evidence for tetrahydrocannabinol: cannabidiol oromucosal spray from randomized clinical trials2019 | Third Faculty of Medicine
- Current practical approaches to investigation and management of chronic urticaria2015 | First Faculty of Medicine
- Monitoring of up to 15 years effects of lipoprotein apheresis on lipids, biomarkers of inflammation, and soluble endoglin in familial hypercholesterolemia patients2021 | Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
- Dulaglutid2016 | Second Faculty of Medicine